Retraction notices · Reasons
Concerns/Issues about Results and/or Conclusions
- Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis1/24/2022 0:00
- Paneth's disease1/24/2022 0:00
- Complications and clinical outcome in chronic pouchitis patients treated with long-term antibiotic therapy1/24/2022 0:00
- Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn’s Disease1/24/2022 0:00
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations1/24/2022 0:00
- IBD: In Food We Trust1/24/2022 0:00
- Alterations of Enteric Microbiota in Patients with a Normal Ileal Pouch Are Predictive of Pouchitis1/24/2022 0:00
- Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City2/4/2022 0:00
- Kaempferol promotes proliferation, migration and differentiation of MC3T3-E1 cells via up-regulation of microRNA-1012/3/2022 0:00
- Exosomal miR-320d derived from adipose tissue-derived MSCs inhibits apoptosis in cardiomyocytes with atrial fibrillation (AF)2/3/2022 0:00
- Emodin protects against lipopolysaccharide-induced inflammatory injury in HaCaT cells through upregulation of miR-212/3/2022 0:00
- Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis1/24/2022 0:00
- The current place of probiotics in treatment of pouchitis: systematic review1/24/2022 0:00
- Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis1/24/2022 0:00
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management1/24/2022 0:00
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders1/24/2022 0:00
- Whipping Crohn’s With Helminth Therapies? Not Yet1/24/2022 0:00
- No shared mechanisms among “old” and “new” VSL#3: Implications for claims and guidelines1/24/2022 0:00
- The impact of trophic effects of multi strain probiotic preparation on paracellular permeability1/24/2022 0:00
- Gut Barrier Dysfunction—A Primary Defect in Twins with Crohn’s Disease Predominantly Caused by Genetic Predisposition1/24/2022 0:00
- Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic1/24/2022 0:00
- Evaluation of the probiotic features of two different multi-strain probiotic preparations from two different manufacturers1/24/2022 0:00
- European Crohn’s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease1/24/2022 0:00
- Perioperative Dietary Therapy in Inflammatory Bowel Disease1/24/2022 0:00
- The anti-inflammatory effects of a poly-probiotic on the oral mucosa1/24/2022 0:00
- Post-marketing evaluation of reported adverse events of a multi-strain probiotic product confirms that change in manufacturing site had no impact on safety profile1/24/2022 0:00
- Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD1/24/2022 0:00
- Overexpression of Vitamin D Receptor in Intestinal Epithelia Protects Against Colitis via Upregulating Tight Junction Protein Claudin 151/24/2022 0:00
- ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease1/24/2022 0:00
- Alteration in Urease-producing Bacteria in the Gut Microbiomes of Patients with Inflammatory Bowel Diseases1/24/2022 0:00
- ECCO Topical Review: Refractory Inflammatory Bowel Disease1/24/2022 0:00
- The effect of vitamin D on an animal model of inflammatory bowel disease related colon cancer1/24/2022 0:00
- The IL-6 trans-signalling pathway and activation pattern of STAT3 in inflammatory bowel disease1/24/2022 0:00
- Unexpected role of anticoagulation protein C in controlling epithelial barrier integrity and intestinal inflammation1/24/2022 0:00
- Preparing Australasian medical students to practise environmentally sustainable health care2/7/2022 0:00
- LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p12/23/2021 0:00
- Lack of tolerization and cross-tolerization of intestinal mesenchymal and endothelial cells to bacterial products and TNF-a: A novel mechanism to sustain and amplify gut inflammation1/24/2022 0:00
- Anti-TNF induced inhibition of T cell proliferation in a mixed lymphocyte reaction is Fc receptor dependent1/24/2022 0:00
- Thrombocytosis in IBD: Iron deficiency driving megakaryopoiesis and platelet aggregation1/24/2022 0:00
- Hydrogeochemical behavior of arsenic-enriched groundwater in the deltaic environment: comparison between two study sites in West Bengal, India3/14/2012 0:00
- Bacterial DNA modulates human beta-defensin 2 expression in neutrophils of NOD-2/card15 wild-type patients with Crohn’s disease1/24/2022 0:00
- Carcinogenesis in ulcerative colitis: Immunosurveillance mechanisms1/24/2022 0:00
- The anticoagulant protein C system is functionally expressed by mucosal dendritic and is down-regulated in IBD patients1/24/2022 0:00
- IL-17 immunity in pediatric inflammatory bowel disease1/24/2022 0:00
- Boswellic acid, a novel antiinflammatory compound, inhibits acid sphingomyelinase in intestinal cells1/24/2022 0:00
- Critical role of angiogenin, angiopoietin 1 and 2, epidermal growth factor and endostatin in inflammatory bowel disease1/24/2022 0:00
- The effect of glucagon-like peptide-2 on mesenteric blood flow and cardiac parameters in short bowel syndrome patients with intestinal failure1/24/2022 0:00
- Palm oil tocotrienol rich fraction (TRF) reduces extracellular matrix proteins production by counteracting TGFb1 profibrogenic effects in human intestinal fibroblasts1/24/2022 0:00
- Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines2/7/2022 0:00
- Vitamin D3 treatment of Crohn’s disease patients increases interleukin 4 and interleukin 6 production and proliferation in CD4+ T cells1/24/2022 0:00